Fagron Concepts

Nourisil™ MD Silicone Scar Gel
Nourisil™ MD contains a unique blend of silicones and Vitamin E to improve the appearance of scars and maintain the skin’s moisture balance.
Read more
SyrSpend® SF PH4 Liquid and Alka Dry
SyrSpend® SF PH4 is Fagron's innovative oral suspension vehicle, compatible with a wide range of API's and superior to traditional suspension vehicles
Read more
Fagron Advanced Derma - Skin, Hair and Hormones.
An innovative solution for dermatological care.
Read more
View all Fagron Concepts

News

Fagron product Nourisil MD approved for NHS drug tariff
Tuesday, December 19, 2017
A Fagron product has been approved for the NHS drug tariff in England and Wales.
Read more
SyrSpend® SF Compatibility Table Update
Monday, November 20, 2017
The latest update of the SyrSpend® SF compatibility table.
Read more
Introducing Lollibase®
Monday, October 2, 2017
Lollibase® is a dry powdered base for producing sugar-free hard candy type lollipops for oral administration and absorption across the buccal mucosa.
Read more

News archive

Fagron product Nourisil MD approved for NHS drug tariff
Tuesday, December 19, 2017
A Fagron product has been approved for the NHS drug tariff in England and Wales.
Read more
SyrSpend® SF Compatibility Table Update
Monday, November 20, 2017
The latest update of the SyrSpend® SF compatibility table.
Read more
Introducing Lollibase®
Monday, October 2, 2017
Lollibase® is a dry powdered base for producing sugar-free hard candy type lollipops for oral administration and absorption across the buccal mucosa.
Read more
NHS Most Prescribed Specials
Wednesday, September 20, 2017
The NHS prescribes over £100million worth of Specials each year.
Read more
The unique quality of Fagron
Wednesday, September 13, 2017
Fagron UK is renowned for high standards in product quality and documentation. We call it the ‘unique quality of Fagron’.
Read more
Fagron UK Celebrates 10th Birthday
Wednesday, August 9, 2017
Happy Birthday to us!
Read more
Higher turnover and profit for Fagron
Monday, August 7, 2017
Fagron can look back on a strong first half of 2017
Read more
SyrSpend® SF provides a safe solution for pediatrics.
Wednesday, July 26, 2017
The Pharmaceutical Journal warns about exposure to problem excipients for paediatrics.
Read more
Brand New Compatibility Study for SyrSpend® SF!
Wednesday, June 14, 2017
Stability evaluation of 10 most commonly used API's compounded in SyrSpend® SF.
Read more
The Fagron UK team expands!
Friday, April 21, 2017
Fagron UK welcomes a new member to the team
Read more
Fagron Press Release
Thursday, April 20, 2017
Hot off the press! Fagron turnover increases by 7.1% to € 109.9 million
Read more
New Compatibility Studies for Syrspend SF
Monday, March 27, 2017
New studies conducted on Syrspend SF
Read more
SyrSpend® SF Content Uniformity Article available
Monday, March 27, 2017
Read why SyrSpend® SF is a valuable alternative to capsules
Read more
Parabens in oral pharmaceutical preparations
Friday, February 17, 2017
Read this article about Parabens in oral pharmaceutical preparations
Read more
Syrspend® SF PH4 Latest Compatibility Table
Thursday, February 16, 2017
Take a look at our latest compatibility table for Syrspend® SF PH4
Read more